Skip to main content
. 2022 Apr 13;23(6):170. doi: 10.3892/ol.2022.13290

Figure 7.

Figure 7.

Tepotinib promotes apoptosis of WM451 cells by restraining the activation of MET and the PI3K/AKT signaling pathways. (A and B) Apoptosis of WM451 cells treated with or without 10 ng/ml tepotinib and 50 ng/ml HGF was detected using TUNEL staining. Magnification, ×200. (C and D) The expression levels of the apoptosis-related proteins in WM451 cells treated with or without 10 ng/ml tepotinib and 50 ng/ml HGF were detected using western blotting. ***P<0.001 vs. control (DMSO) group; ##P<0.01 and ###P<0.001 vs. tepotinib. MET, MET proto-oncogene, receptor tyrosine kinase; HGF, hepatocyte growth factor.